Their goal is to provide an ongoing, interactive, and open place for users to exchange resources, ideas, information and comments regarding sexual health and facts about sexually transmitted diseases (STDs).
The objective of this presentation is to list and describe the mechanisms of AIDS-associated malignancies, identify and describe oncoviruses seen in the setting of HIV infection, describe the 3 AIDS-defining malignancies, and to develop a basic cancer therapy plan for patients with AIDS-defining malignancies.
NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited.
This guide includes WHO recommendations on screening and treatment of pre-cancer lesions and on HPV vaccination made through April 2014, taking account of relevant evidence-based findings published up to December 2013; emerging practices that are still being evaluated are also noted in this publication. This guide, which replaces the 2006 edition, has two new chapters, one newly organized chapter, and two substantially revised chapters. The new chapters include: Essentials for cervical a=cancer prevention and control programmes; and HPV vaccination.
This manual for clinicians provides guidelines for clinical care of persons with HIV/AIDS. This updated version incorporates many new insights, but the time-tested format has been retained – easy access to crucial facts for a busy clinician. The guide touches on every topic facing people with HIV and their caregivers.
This fact sheet provides information about the progression of the hepatitis C virus (HCV) from an acute infection to a chronic infection. It talks about symptoms, complications, fibrosis, cirrhosis, liver cancer, liver transplants, and treatments.
This guide is designed to help patients understand and manage Hepatitis C Virus (HCV). The guide states that HCV is the leading reason for liver transplants in the U.S. The guide covers HCV transmission, disease progression, symptoms, diagnosis, and treatment options and considerations.